Literature DB >> 22711611

Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.

Darren Mays1, McKane E Sharff, Tiffani A DeMarco, Bernice Williams, Beth Beck, Vanessa B Sheppard, Beth N Peshkin, Jennifer Eng-Wong, Kenneth P Tercyak.   

Abstract

Hereditary breast and ovarian cancer risk assessments (CRAs) are underutilized by low-income and racial/ethnic minority women, potentially exacerbating cancer-related disparities observed within these populations. We deployed and evaluated a systems-level intervention designed to identify patients potentially at-risk for hereditary breast/ovarian cancer, refer them for CRAs, and facilitate CRA utilization at an urban community-based breast health care center. Cancer family history forms were completed by patients seen at the center during an 18-month period and reviewed by staff for CRA eligibility against published referral criteria. A patient navigator educated eligible patients about the benefits of CRA, navigating interested patients to this service. CRA-specific patient interest and utilization outcomes are reported. In total, 94.7 % of all patients (n = 2,436) completed forms and 65 patients (2.7 %) met CRA eligibility criteria. Most eligible patients (72.3 %) were interested in CRA. Interested patients had a greater risk for hereditary breast/ovarian cancer (i.e., more affected relatives, greater objective risk scores) than uninterested patients: 57.4 % scheduled a CRA appointment and 51.9 % of scheduled patients utilized CRAs. Patients scheduling a CRA were contacted in less time and required fewer follow-up contacts by the patient navigator, and were more likely to be African American, than those who declined a CRA or were lost to follow-up (all p's ≤ .05). The systems-level intervention successfully identified patients eligible for CRA and linked interested and at-risk patients with CRA resources. More intensive patient navigation addressing the unique barriers encountered within this population may be required to enhance utilization.

Entities:  

Mesh:

Year:  2012        PMID: 22711611      PMCID: PMC3521596          DOI: 10.1007/s10689-012-9541-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  60 in total

Review 1.  Genetic cancer risk assessment. Putting it all together.

Authors:  J N Weitzel
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

2.  Increasing utilization of cancer genetic counseling services using a patient navigator model.

Authors:  Alanna Kulchak Rahm; Anna Sukhanova; Jennifer Ellis; Judy Mouchawar
Journal:  J Genet Couns       Date:  2007-04       Impact factor: 2.537

3.  Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening.

Authors:  Kent F Hoskins; Alice Zwaagstra; Michael Ranz
Journal:  Cancer       Date:  2006-10-15       Impact factor: 6.860

4.  If we build it ... will they come?--establishing a cancer genetics services clinic for an underserved predominantly Latina cohort.

Authors:  Charité Ricker; Veronica Lagos; Nancy Feldman; Susan Hiyama; Sue Fuentes; Visanth Kumar; Kelly Gonzalez; Melanie Palomares; Kathleen Blazer; Katrina Lowstuter; Deborah MacDonald; Jeffrey Weitzel
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

Review 5.  BRCA1/2 testing: complex themes in result interpretation.

Authors:  B N Peshkin; T A DeMarco; B M Brogan; C Lerman; C Isaacs
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

6.  BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.

Authors:  Kristen J Vogel; Deann P Atchley; Julie Erlichman; Kristine R Broglio; Kaylene J Ready; Vicente Valero; Christopher I Amos; Gabriel N Hortobagyi; Karen H Lu; Banu Arun
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

Review 7.  Interventions to enhance breast cancer screening, diagnosis, and treatment among racial and ethnic minority women.

Authors:  Christopher M Masi; Dionne J Blackman; Monica E Peek
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

8.  Interest, awareness, and perceptions of genetic testing among Hispanic family members of breast cancer survivors.

Authors:  Amelie G Ramirez; Fabiola E Aparicio-Ting; Sandra San Miguel de Majors; Alexander R Miller
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

9.  Meta-analysis of BRCA1 and BRCA2 penetrance.

Authors:  Sining Chen; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

Review 10.  Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors.

Authors:  Janice L Berliner; Angela Musial Fay
Journal:  J Genet Couns       Date:  2007-05-17       Impact factor: 2.717

View more
  14 in total

1.  Diversity in the Era of Precision Medicine - From Bench to Bedside Implementation.

Authors:  Abdullah Mamun; Nana Y Nsiah; Meenakshi Srinivasan; Ayyappa Chaturvedula; Riyaz Basha; Deanna Cross; Harlan P Jones; Karabi Nandy; Jamboor K Vishwanatha
Journal:  Ethn Dis       Date:  2019-07-18       Impact factor: 1.847

2.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

3.  Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.

Authors:  Emily E Anderson; Silvia Tejeda; Kimberly Childers; Melinda R Stolley; Richard B Warnecke; Kent F Hoskins
Journal:  J Oncol Pract       Date:  2015-06-02       Impact factor: 3.840

4.  The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.

Authors:  Alejandra Hurtado-de-Mendoza; Monica C Jackson; Lyndsay Anderson; Vanessa B Sheppard
Journal:  J Genet Couns       Date:  2016-07-12       Impact factor: 2.537

5.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

6.  Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.

Authors:  Rena J Pasick; Galen Joseph; Susan Stewart; Celia Kaplan; Robin Lee; Judith Luce; Sharon Davis; Titas Marquez; Tung Nguyen; Claudia Guerra
Journal:  Am J Public Health       Date:  2016-08-23       Impact factor: 9.308

7.  The KinFact intervention - a randomized controlled trial to increase family communication about cancer history.

Authors:  Joann N Bodurtha; Donna McClish; Maria Gyure; Rosalie Corona; Alexander H Krist; Vivian M Rodríguez; Alisa M Maibauer; Joseph Borzelleca; Deborah J Bowen; John M Quillin
Journal:  J Womens Health (Larchmt)       Date:  2014-10       Impact factor: 2.681

8.  Relationships of Family History-related Factors and Causal Beliefs to Cancer Risk Perception and Mammography Screening Adherence Among Medically Underserved Women.

Authors:  Soo Jung Hong; Melody Goodman; Kimberly A Kaphingst
Journal:  J Health Commun       Date:  2020-07-16

9.  Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research.

Authors:  Emily E Anderson; Kent Hoskins
Journal:  J Health Care Poor Underserved       Date:  2012-11

10.  Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion.

Authors:  Jessica E Ebrahimzadeh; Jessica M Long; Louise Wang; John T Nathanson; Shazia Mehmood Siddique; Anil K Rustgi; David S Goldberg; Bryson W Katona
Journal:  J Genet Couns       Date:  2020-03-30       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.